Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study

G. Folprecht, C. Pericay, M. P. Saunders, A. Thomas, R. Lopez Lopez, J. K. Roh, V. Chistyakov, T. Höhler, J. S. Kim, R. D. Hofheinz, S. P. Ackland, D. Swinson, M. Kopp, D. Udovitsa, M. Hall, T. Iveson, A. Vogel, J. R. Zalcberg

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science